EPO Patents = 4

Forward Citations = 4

Loading Chart...

16 inventors (with patents filed for the assignee):

David Harrison (6 out of 8 patents)

Alan Paul Watt (5 out of 5 patents)

Mark G Bock (5 out of 5 patents)

4. Oleksandr Levenets (2 out of 2 patents)

5. Nicolas Boutard (1 out of 1 patent)

6. Charles-Henry Fabritius (1 out of 4 patents)

7. Piotr Kowalczyk (1 out of 1 patent)

8. Jakub Woyciechowski (1 out of 1 patent)

9. Michal Galezowski (1 out of 6 patents)

10. Roderick Alan Porter (1 out of 1 patent)

11. Jane E Scanlon (1 out of 1 patent)

12. Charles-Henry Robert Yves Fabritius (1 out of 2 patents)

13. Grzegorz Witold Topolnicki (1 out of 3 patents)

14. Nicolas Felix Pierre Boutard (1 out of 1 patent)

15. Charles-Henry Robert Yves Fabritius (0 patent)

6 patents: Sort by Forward Citations

1. 12459925 - Sulphonyl urea derivatives as NLRP3 inflammasome modulators (2025-11-04),

2. 12247011 - Selective inhibitors of NLRP3 inflammasome (2025-03-11),

3. 12054461 - Sulfonylurea derivatives and uses thereof (2024-08-06),

4. 12012397 - Sulphonyl urea derivatives as NLRP3 inflammasome modulators (2024-06-18),

5. 11518757 - Sulphonyl urea derivatives as NLRP3 inflammasome modulators (2022-12-06),

6. 11345669 - Urea derivatives and methods of use thereof (2022-05-31),

Nodthera Limited is a biotechnology company focused on developing innovative small molecule therapeutics for the treatment of inflammatory diseases. Our team of experienced scientists is dedicated to pioneering research in the field of innate immunity, with a particular focus on NLRP3 inflammasome modulation. Through our cutting-edge approach, we aim to address the unmet medical needs of patients suffering from chronic inflammatory conditions.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

6 Patents

#16 in Essex

#2,615 in United Kingdom

Essex, United Kingdom

Nodthera Limited